Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Janssen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Expert Review of Anti-Infective Therapy|March 24, 2015
Bedaquiline for the treatment of drug-resistant tuberculosisSabine Bélard, Charlotte C Heuvelings, Saskia Janssen, et al.
Respirology (Carlton, Vic.)|January 31, 2025
Tuberculosis: An Update for the ClinicianSaskia Janssen, Melissa Murphy, Caryn Upton, et al.
The Pediatric Infectious Disease Journal|November 24, 2021
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of GestationKatrin Mehler, Oliver Cornely, Harald Seifert, et al.
Drug Design, Development and Therapy|September 14, 2012
Exploring prospects of novel drugs for tuberculosisSaskia Janssen, Rajesh Jayachandran, Lulama Khathi, et al.
BMC Health Services Research|July 11, 2013
Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based studyDeliwe Nkosi, Saskia Janssen, Xavier Padanilam, et al.
Antiviral Therapy|October 25, 2013
Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entitySaskia Janssen, Elie G Rossatanga, Suzanne Jurriaans, et al.
Plos Neglected Tropical Diseases|August 23, 2013
Helminthic infections rates and malaria in HIV-infected pregnant women on anti-retroviral therapy in RwandaEmil Ivan, Nigel J Crowther, Eugene Mutimura, et al.
Journal of Public Health (Oxford, England)|December 21, 2014
Limited access to drugs for resistant tuberculosis: a call to actionSabine Bélard, Saskia Janssen, Kara K Osbak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2014
Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from RwandaEmil Ivan, Nigel J Crowther, Eugene Mutimura, et al.
Journal of Clinical Microbiology|December 11, 2012
How many sputum culture results do we need to monitor multidrug-resistant-tuberculosis (MDR-TB) patients during treatment?Saskia Janssen, Xavier Padanilam, Rianna Louw, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Expert Review of Anti-Infective Therapy|March 24, 2015
Bedaquiline for the treatment of drug-resistant tuberculosisSabine Bélard, Charlotte C Heuvelings, Saskia Janssen, et al.
Respirology (Carlton, Vic.)|January 31, 2025
Tuberculosis: An Update for the ClinicianSaskia Janssen, Melissa Murphy, Caryn Upton, et al.
The Pediatric Infectious Disease Journal|November 24, 2021
Molds and More: Rare Fungal Infections in Preterm Infants <24 Weeks of GestationKatrin Mehler, Oliver Cornely, Harald Seifert, et al.
Drug Design, Development and Therapy|September 14, 2012
Exploring prospects of novel drugs for tuberculosisSaskia Janssen, Rajesh Jayachandran, Lulama Khathi, et al.
BMC Health Services Research|July 11, 2013
Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based studyDeliwe Nkosi, Saskia Janssen, Xavier Padanilam, et al.
Antiviral Therapy|October 25, 2013
Triple infection with HIV-1, HTLV-1 and Strongyloides stercoralis, rendering CD4+ T-cell counts a misleading entitySaskia Janssen, Elie G Rossatanga, Suzanne Jurriaans, et al.
Plos Neglected Tropical Diseases|August 23, 2013
Helminthic infections rates and malaria in HIV-infected pregnant women on anti-retroviral therapy in RwandaEmil Ivan, Nigel J Crowther, Eugene Mutimura, et al.
Journal of Public Health (Oxford, England)|December 21, 2014
Limited access to drugs for resistant tuberculosis: a call to actionSabine Bélard, Saskia Janssen, Kara K Osbak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2014
Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from RwandaEmil Ivan, Nigel J Crowther, Eugene Mutimura, et al.
Journal of Clinical Microbiology|December 11, 2012
How many sputum culture results do we need to monitor multidrug-resistant-tuberculosis (MDR-TB) patients during treatment?Saskia Janssen, Xavier Padanilam, Rianna Louw, et al.
Pageof 4